Actinium Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $90 | $0 |
Gross Profit | -220 | 615 | 90 | -204 |
EBITDA | -5,683 | -6,208 | -5,486 | -7,299 |
EBIT | -5,903 | -6,414 | -5,692 | -7,503 |
Net Income | -5,522 | -5,940 | -5,131 | -6,878 |
Net Change In Cash | 0 | 0 | 90 | 0 |
Free Cash Flow | -5,872 | -5,393 | -6,325 | -5,392 |
Cash | 42,132 | 47,998 | 53,391 | 59,928 |
Basic Shares | 31,237 | 31,195 | 31,195 | 31,195 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $90 | $0 | $81 | $1,030 |
Gross Profit | 90 | -811 | 81 | 1,030 |
EBITDA | -35,426 | -37,432 | -51,130 | -33,405 |
EBIT | -36,247 | -38,243 | -51,920 | -34,104 |
Net Income | -33,887 | -38,243 | -48,818 | -33,017 |
Net Change In Cash | 90 | 0 | 81 | 1,030 |
Free Cash Flow | -24,684 | -33,083 | -47,488 | 8,278 |
Cash | 47,998 | 72,904 | 76,677 | 108,910 |
Basic Shares | 31,195 | 30,070 | 26,604 | 24,142 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.18 |
2025-12-31 | -$0.19 |
2025-09-30 | -$0.16 |
2025-06-30 | -$0.22 |